WNT10A/β-catenin pathway in tumorigenesis of papillary thyroid carcinoma

被引:18
|
作者
Dong, Tianyi [1 ]
Zhang, Zhun [2 ]
Zhou, Wenhong [3 ]
Zhou, Xiangyu [1 ]
Geng, Chong [2 ]
Chang, Lap Kam [1 ]
Tian, Xingsong [2 ]
Liu, Shili [1 ]
机构
[1] Shandong Univ, Sch Med, Jinan 250012, Shandong, Peoples R China
[2] Shandong Univ, Shandong Prov Hosp, Dept Breast Thyroid Surg, Jinan, Shandong, Peoples R China
[3] Shandong Univ, Shandong Prov Hosp, Dept Nursing, Jinan 250021, Shandong, Peoples R China
基金
中国国家自然科学基金;
关键词
papillary thyroid carcinoma; WNT10A; beta-catenin; late apoptosis; CANCER STEM-CELLS; BETA-CATENIN; WNT10A; EXPRESSION; PROMOTES; METASTASIS; APOPTOSIS; DICKKOPF-1; PROTEINS; HEDGEHOG;
D O I
10.3892/or.2017.5777
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Papillary thyroid carcinoma is the most common thyroid cancer and the incidence is increasing. Aberrant activation of the WNT/beta-catenin pathway plays an important role in carcinogenesis. In the present study, microarray analysis was employed to compare tissues from papillary thyroid cancer and adjacent normal tissues to determine candidate genes facilitating tumor invasion. The result demonstrated that genes involved in WNT/beta-catenin signaling pathway were activated in papillary thyroid cancer, WNT10A expression was found to be upregulated >4-fold. The variations in gene expression were verified in tissues obtained from other papillary thyroid cancer patients. Molecular mechanism exploration in thyroid cells showed that enhanced WNT10A/beta-catenin signaling pathway activation promoted cell proliferation and migration. The promotion was validated by RNA interference of WNT10A and LEF1 expression. Moreover, results from flow cytometry demonstrated that WNT/beta-catenin signaling pathway activation reduced the percentage of late apoptotic thyroid cells. Conclusively, the results suggest for the first time that WNT10A/beta-catenin signaling pathway plays a crucial role in human papillary thyroid cancer.
引用
收藏
页码:1287 / 1294
页数:8
相关论文
共 50 条
  • [31] Chromobox 4 facilitates tumorigenesis of lung adenocarcinoma Wnt/β-catenin pathway
    Wang, Zuoyun
    Fang, Zhaoyuan
    Chen, Gaobin
    Liu, Bo
    Xu, Jinjin
    Li, Fei
    Li, Fuming
    Liu, Hongyan
    Zhang, Haoen
    Sun, Yihua
    Tian, Gang
    Chen, Haiquan
    Xu, Guoliang
    Zhang, Lei
    Hu, Liang
    Ji, Hongbin
    NEOPLASIA, 2021, 23 (02): : 222 - 233
  • [32] Expression of beta-catenin in the papillary thyroid carcinoma
    Caruntu, I. -D.
    Giusca, S. E.
    Lozneanu, L.
    Ciobanu, D. Apostol
    Andriescu, E. C.
    VIRCHOWS ARCHIV, 2018, 473 : S252 - S253
  • [33] Blockers of Wnt3a, Wnt10a, or β-Catenin Prevent Chemotherapy-Induced Neuropathic Pain In Vivo
    Kim, Hee Kee
    Bae, Jingi
    Lee, Sung Ho
    Hwang, Seon-Hee
    Kim, Min-Sik
    Kim, Moon Jong
    Jun, Sohee
    Cervantes, Chris L.
    Jung, Youn-Sang
    Back, Seunghoon
    Lee, Hangyeore
    Lee, Seung-Eun
    Dougherty, Patrick M.
    Lee, Sang-Won
    Park, Jae-Il
    Abdi, Salahadin
    NEUROTHERAPEUTICS, 2021, 18 (01) : 601 - 614
  • [34] Blockers of Wnt3a, Wnt10a, or β-Catenin Prevent Chemotherapy-Induced Neuropathic Pain In Vivo
    Hee Kee Kim
    Jingi Bae
    Sung Ho Lee
    Seon-Hee Hwang
    Min-Sik Kim
    Moon Jong Kim
    Sohee Jun
    Chris L. Cervantes
    Youn-Sang Jung
    Seunghoon Back
    Hangyeore Lee
    Seung-Eun Lee
    Patrick M. Dougherty
    Sang-Won Lee
    Jae-Il Park
    Salahadin Abdi
    Neurotherapeutics, 2021, 18 : 601 - 614
  • [35] FOXN3 suppresses the growth and invasion of papillary thyroid cancer through the inactivation of Wnt/β-catenin pathway
    Zhao, Chang'an
    Mo, Liping
    Li, Chao
    Han, Shuiping
    Zhao, Wenbo
    Liu, Lifeng
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2020, 515
  • [36] Silencing of AHNAK2 restricts thyroid carcinoma progression by inhibiting the Wnt/β-catenin pathway
    Lin, Qiu-Yu
    Qi, Qian-Le
    Hou, Sen
    Chen, Zhen
    Jiang, Nan
    Zhang, Laney
    Lin, Cheng-He
    NEOPLASMA, 2021, 68 (05) : 1063 - 1071
  • [37] Expression of WNT10A in human cancer
    Kirikoshi, H
    Inoue, S
    Sekihara, H
    Katoh, M
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2001, 19 (05) : 997 - 1001
  • [38] RETRACTION: TIPE2 suppresses progression and tumorigenesis of esophageal carcinoma via inhibition of the Wnt/β-catenin pathway
    Zhu, Linan
    Zhang, Xudong
    Fu, Xiaorui
    Li, Zhaoming
    Sun, Zhenchang
    Wu, Jingjing
    Wang, Xinhua
    Wang, Feng
    Li, Xiangke
    Niu, Songtao
    Ding, Mengjie
    Yang, Zhenzhen
    Yang, Wanqiu
    Yin, Meifeng
    Zhang, Lei
    Zhang, Mingzhi
    JOURNAL OF TRANSLATIONAL MEDICINE, 2024, 22 (01)
  • [39] RETRACTED ARTICLE: Dickkopf-1 contributes to hepatocellular carcinoma tumorigenesis by activating the Wnt/β-catenin signaling pathway
    Rui Zhang
    Hao-Ming Lin
    Ruth Broering
    Xiang-de Shi
    Xian-huan Yu
    Lei-bo Xu
    Wen-rui Wu
    Chao Liu
    Signal Transduction and Targeted Therapy, 4
  • [40] Retraction Note: Dickkopf-1 contributes to hepatocellular carcinoma tumorigenesis by activating the Wnt/β-catenin signaling pathway
    Rui Zhang
    Hao-Ming Lin
    Ruth Broering
    Xiang-de Shi
    Xian-huan Yu
    Lei-bo Xu
    Wen-rui Wu
    Chao Liu
    Signal Transduction and Targeted Therapy, 8